NASDAQ : DNTH
Dianthus Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 82.38 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 4.61B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Dianthus Therapeutics, Inc. (DNTH) reported revenue of 1.90M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 1.90M | 2.04M | 6.24M | 2.83M | 6.42M | 1.48M |
| Gross Profit | 1.90M | 2.04M | 6.24M | 2.83M | 6.42M | 1.48M |
| Selling, General & Admin | 44.13M | 34.33M | 24.99M | 18.16M | 6.74M | 1.96M |
| Research & Development | 175.62M | 145.64M | 83.11M | 32.84M | 29.38M | 12.61M |
| Operating Expenses | 219.75M | 179.97M | 108.10M | 51.00M | 36.12M | 14.56M |
| Operating Income | -217.84M | -177.93M | -101.86M | -48.17M | -29.70M | -13.09M |
| Interest & Investment Income | 16.69M | 9.96M | 11.35M | 4.76M | 1.15M | 3.00K |
| Currency Exchange Gain (Loss) | -30.00K | -57.00K | -64.00K | -85.00K | 136.00K | -26.00K |
| Other Non Operating Income (Expenses) | -1.39M | -974.00K | -554.00K | -60.00K | -52.00K | |
| EBT Excluding Unusual Items | -202.57M | -169.01M | -91.14M | -43.55M | -28.48M | -13.11M |
| Gain (Loss) on Sale of Investments | 10.32M | 6.67M | 6.17M | |||
| Pretax Income | -192.25M | -162.34M | -84.97M | -43.55M | -28.48M | -13.11M |
| Net Income | -192.25M | -162.34M | -84.97M | -43.55M | -28.48M | -13.11M |
| Net Income to Common | -192.25M | -162.34M | -84.97M | -43.55M | -28.48M | -13.11M |
| Shares Outstanding (Basic) | 46.74M | 38.62M | 33.31M | 5.15M | 874.23K | 4.01M |
| Shares Outstanding (Diluted) | 46.74M | 38.62M | 33.31M | 5.15M | 874.23K | 4.01M |
| EPS (Basic) | -4.11 | -4.20 | -2.55 | -8.45 | -32.57 | -3.27 |
| EPS (Diluted) | -4.11 | -4.20 | -2.55 | -8.45 | -32.57 | -3.27 |
| Free Cash Flow | -155.71M | -129.27M | -78.28M | -36.97M | -29.21M | -9.94M |
| Free Cash Flow Per Share | -3.33 | -3.35 | -2.35 | -7.17 | -33.41 | -2.48 |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Margin | -11,441.39% | -8,739.34% | -1,633.75% | -1,704.67% | -462.91% | -886.59% |
| Profit Margin | -10,096.95% | -7,973.33% | -1,362.78% | -1,541.22% | -443.76% | -888.14% |
| Free Cash Flow Margin | -8,177.99% | -6,349.36% | -1,255.57% | -1,308.24% | -455.18% | -673.24% |
| EBITDA | -217.72M | -177.82M | -101.77M | -48.11M | -29.68M | |
| D&A For EBITDA | 123.00K | 111.00K | 96.00K | 67.00K | 30.00K | |
| EBIT | -217.84M | -177.93M | -101.86M | -48.17M | -29.70M | -13.09M |
| Revenue as Reported | 2.04M | 2.04M | 6.24M | 2.83M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 110.55M | 51.09M | 22.79M | 132.32M | 15.37M | 7.64M |
| Short-Term Investments | 776.26M | 353.21M | 252.45M | 41.39M | 60.12M | |
| Cash & Short-Term Investments | 886.81M | 404.30M | 275.24M | 173.72M | 75.49M | 7.64M |
| Receivables | 106.00K | 52.00K | 807.00K | 478.00K | 5.64M | 1.48M |
| Inventory | 7.83M | 3.03M | 3.04M | 2.15M | 820.00K | 243.00K |
| Prepaid Expenses | 2.61M | 1.97M | 1.47M | 1.10M | 85.00K | 21.00K |
| Other Current Assets | 184.00K | 86.00K | 355.00K | 10.00K | ||
| Total Current Assets | 897.54M | 409.44M | 280.90M | 177.45M | 82.03M | 9.39M |
| Property, Plant & Equipment | 1.64M | 1.63M | 1.75M | 800.00K | 956.00K | 33.00K |
| Long-Term Investments | 304.09M | 110.14M | 81.73M | |||
| Other Long-Term Assets | 10.00M | 9.72M | 9.63M | 1.15M | 121.00K | 30.00K |
| Total Assets | 1.21B | 530.92M | 374.01M | 179.41M | 83.11M | 9.45M |
| Accounts Payable | 6.39M | 9.72M | 4.58M | 2.61M | 1.17M | 1.36M |
| Accrued Expenses | 24.91M | 19.45M | 13.07M | 6.50M | 6.61M | 3.99M |
| Current Portion of Leases | 374.00K | 367.00K | 320.00K | 417.00K | 350.00K | |
| Current Unearned Revenue | 1.52M | 1.19M | 479.00K | 100.00K | 100.00K | |
| Total Current Liabilities | 34.39M | 30.73M | 18.45M | 9.63M | 8.22M | 5.35M |
| Long-Term Leases | 913.00K | 1.02M | 1.17M | 168.00K | 438.00K | |
| Long-Term Unearned Revenue | 5.94M | 5.77M | 1.91M | 736.00K | 791.00K | |
| Total Liabilities | 41.25M | 37.52M | 21.53M | 10.54M | 9.45M | 5.35M |
| Common Stock | 55.00K | 43.00K | 31.00K | 15.00K | ||
| Additional Paid-In Capital | 1.60B | 829.60M | 526.73M | 258.23M | 1.66M | 143.00K |
| Retained Earnings | -427.78M | -336.73M | -174.39M | -89.42M | -45.87M | -17.39M |
| Comprehensive Income & Other | -2.13M | 489.00K | 106.00K | 47.00K | -161.00K | |
| Total Common Equity | 1.17B | 493.40M | 352.48M | 168.87M | -44.37M | -17.25M |
| Shareholders' Equity | 1.17B | 493.40M | 352.48M | 168.87M | 73.66M | 4.10M |
| Total Liabilities & Equity | 1.21B | 530.92M | 374.01M | 179.41M | 83.11M | 9.45M |
| Total Debt | 1.29M | 1.39M | 1.49M | 585.00K | 788.00K | |
| Net Cash (Debt) | 1.19B | 513.04M | 355.48M | 173.13M | 74.70M | 7.64M |
| Net Cash Per Share | 25.44 | 13.29 | 10.67 | 33.60 | 85.45 | 1.91 |
| Filing Date Shares Outstanding | 55.93M | 44.47M | 32.13M | 29.35M | 4.01M | 4.01M |
| Total Common Shares Outstanding | 54.80M | 43.22M | 31.12M | 14.82M | 875.28K | 4.01M |
| Working Capital | 863.15M | 378.71M | 262.45M | 167.82M | 73.81M | 4.04M |
| Book Value Per Share | 21.39 | 11.42 | 11.33 | 11.40 | -50.69 | -4.31 |
| Tangible Book Value | 1.17B | 493.40M | 352.48M | 168.87M | -44.37M | -17.25M |
| Tangible Book Value Per Share | 21.39 | 11.42 | 11.33 | 11.40 | -50.69 | -4.31 |
| Machinery | 791.00K | 600.00K | 387.00K | 282.00K | 172.00K | |
| Construction In Progress | 33.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -192.25M | -162.34M | -84.97M | -43.55M | -28.48M | -13.11M |
| Depreciation & Amortization | 379.00K | 428.00K | 412.00K | 355.00K | 147.00K | |
| Loss (Gain) From Sale of Investments | -10.32M | -6.67M | -6.17M | -1.42M | -606.00K | |
| Stock-Based Compensation | 34.27M | 22.79M | 12.89M | 2.90M | 1.52M | 63.00K |
| Change in Accounts Receivable | -67.00K | -52.00K | 184.00K | 754.00K | 69.00K | -1.01M |
| Change in Accounts Payable | 12.90M | 11.28M | 8.19M | 661.00K | 2.28M | 4.92M |
| Change in Unearned Revenue | 5.20M | 4.57M | 1.55M | -55.00K | 891.00K | |
| Change in Other Net Operating Assets | -5.50M | 930.00K | -10.28M | 3.50M | -4.89M | -770.00K |
| Operating Cash Flow | -155.38M | -129.06M | -78.18M | -36.86M | -29.07M | -9.90M |
| Capital Expenditures | -334.00K | -213.00K | -105.00K | -110.00K | -139.00K | -33.00K |
| Investment in Securities | -776.23M | -122.62M | -286.71M | 20.36M | -59.68M | |
| Investing Cash Flow | -776.56M | -122.83M | -286.81M | 20.25M | -59.82M | -33.00K |
| Short-Term Debt Issued | 377.00K | |||||
| Total Debt Issued | 377.00K | |||||
| Short-Term Debt Repaid | -377.00K | |||||
| Total Debt Repaid | -377.00K | |||||
| Issuance of Common Stock | 1.03B | 280.49M | 270.29M | 5.00K | ||
| Other Financing Activities | -1.91M | -364.00K | -14.66M | 133.57M | -3.32M | -88.00K |
| Financing Cash Flow | 1.03B | 280.12M | 255.62M | 133.57M | 96.68M | 14.91M |
| Net Cash Flow | 97.25M | 28.23M | -109.37M | 116.97M | 7.79M | 4.97M |
| Free Cash Flow | -155.71M | -129.27M | -78.28M | -36.97M | -29.21M | -9.94M |
| Free Cash Flow Margin | -8,177.99% | -6,349.36% | -1,255.57% | -1,308.24% | -455.18% | -673.24% |
| Free Cash Flow Per Share | -3.33 | -3.35 | -2.35 | -7.17 | -33.41 | -2.48 |
| Levered Free Cash Flow | -92.21M | -75.45M | -43.48M | -22.81M | -19.31M | |
| Unlevered Free Cash Flow | -92.21M | -75.45M | -43.48M | -22.81M | -19.31M | |
| Change in Working Capital | 12.54M | 16.73M | -351.00K | 4.86M | -1.65M | 3.14M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 4.60B | 1.77B | 645.21M | 154.10M | ||
| Enterprise Value | 3.41B | 1.21B | 364.40M | -35.10M | ||
| Last Close Price | 82.25 | 41.21 | 21.80 | 10.40 | ||
| PS Ratio | 2,416.28 | 867.84 | 103.48 | 54.53 | ||
| PB Ratio | 3.85 | 3.58 | 1.83 | 0.91 | ||
| P/TBV Ratio | 3.93 | 3.58 | 1.83 | 0.91 | ||
| EV/Sales Ratio | 1,791.72 | 595.64 | 58.45 | |||
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| Net Debt / Equity Ratio | -1.01 | -1.04 | -1.01 | -1.02 | -1.01 | -1.86 |
| Net Debt / EBITDA Ratio | 5.46 | 2.88 | 3.49 | 3.60 | 2.52 | |
| Net Debt / FCF Ratio | 7.64 | 3.97 | 4.54 | 4.68 | 2.56 | 0.77 |
| Asset Turnover | 0.00 | 0.00 | 0.02 | 0.02 | 0.14 | |
| Quick Ratio | 25.79 | 13.16 | 14.96 | 18.09 | 9.86 | 1.70 |
| Current Ratio | 26.10 | 13.32 | 15.22 | 18.43 | 9.97 | 1.75 |
| Return on Equity (ROE) | -26.06% | -38.38% | -32.60% | -35.92% | -73.25% | |
| Return on Assets (ROA) | -17.69% | -24.58% | -23.01% | -22.94% | -40.12% | |
| Return on Capital Employed (ROCE) | -18.50% | -35.60% | -28.60% | -28.40% | -39.70% | -319.20% |
| Earnings Yield | -5.00% | -9.19% | -13.17% | -28.26% | ||
| FCF Yield | -3.38% | -7.32% | -12.13% | -23.99% | ||
| Buyback Yield / Dilution | -32.34% | -15.92% | -546.44% | -489.48% | 78.17% |